Earth Science Tech (ETST) Operating Income (2011 - 2026)
Earth Science Tech (ETST) posted Operating Income of $1.1 million for Q1 2026, down 14.88% on a QoQ basis from $1.3 million in Q4 2025, and down 13.92% year-over-year from $1.3 million in Q1 2025.
Earth Science Tech (ETST) Operating Income (2011 - 2026) Analysis & Trends
Earth Science Tech's Operating Income history runs 15 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Operating Income fell 13.92% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (down 4.04% YoY) and the FY2026 annual result came in at $3.3 million, down 4.04% from the prior year.
- Operating Income was $1.1 million for Q1 2026 at Earth Science Tech, down from $1.3 million in the prior quarter.
- Across five years, Operating Income topped out at $1.3 million in Q4 2025 and bottomed at -$692172.0 in Q2 2022.
- A 5-year average of $394021.1 and a median of $241631.0 in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income sank 5896.98% — and 2024, when it jumped 4734.95%.
- Earth Science Tech's Operating Income stood at -$48275.0 in 2022, then jumped by 578.57% to $231031.0 in 2023, then fell by 2.08% to $226226.0 in 2024, then surged by 493.22% to $1.3 million in 2025, then retreated by 14.88% to $1.1 million in 2026.
- Business Quant data shows ETST's Operating Income at $1.1 million in Q1 2026, $1.3 million in Q4 2025, and $582618.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 325.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Earth Science Tech | 34.44 Mn | 32.28 Mn | 6.27 Mn | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | 582,618.00 |
| Jun 30, 2025 | 241,631.00 |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 226,226.00 |
| Sep 30, 2024 | 829,560.00 |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 258,485.00 |
| Dec 31, 2023 | 231,031.00 |
| Sep 30, 2023 | 479,944.00 |
| Jun 30, 2023 | -22,978.00 |
| Mar 31, 2023 | -119,323.00 |
| Dec 31, 2022 | -48,275.00 |
| Sep 30, 2022 | -76,913.00 |
| Jun 30, 2022 | -692,172.00 |
| Mar 31, 2022 | -68,023.00 |
| Dec 31, 2021 | -100,951.00 |
| Sep 30, 2021 | -46,190.00 |
| Jun 30, 2021 | -11,542.00 |